Adnan Nagrial
- Oncology top 1%
- Molecular Biology top 10%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Co-authors
- Richard KeffordRichard A. ScolyerGeorgina V. LongAlexander M. MenziesMichael HughesLauren E. HayduGraham J. MannAnne Hamilton
- Topics
- Cancer Immunotherapy and Biomarkers (43 papers)Pancreatic and Hepatic Oncology Research (36 papers)Cancer Genomics and Diagnostics (28 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaGastroenterology
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Adnan Nagrial
112 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 2.5k
- Molecular Biology 1.1k
- Surgery 837
- Pulmonary and Respiratory Medicine 698
- Cancer Research 453
Countries citing papers authored by Adnan Nagrial
This map shows the geographic impact of Adnan Nagrial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adnan Nagrial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adnan Nagrial more than expected).
Fields of papers citing papers by Adnan Nagrial
This network shows the impact of papers produced by Adnan Nagrial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adnan Nagrial. The network helps show where Adnan Nagrial may publish in the future.
Co-authorship network of co-authors of Adnan Nagrial
This figure shows the co-authorship network connecting the top 25 collaborators of Adnan Nagrial. A scholar is included among the top collaborators of Adnan Nagrial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adnan Nagrial. Adnan Nagrial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | 0 | |
| 10 | 12 | |
| 11 | 4 | |
| 12 | 23 | |
| 13 | 13 | |
| 14 | 0 | |
| 15 | 116 | |
| 16 | 26 | |
| 17 | Preliminary Results of A Phase I/IIA Study of BMS-986156 (GLUCOCORTICOID-Induced Tumour Necrosis Factor Receptor-Related Gene [GITR] AGONIST), Alone and In Combination with Nivolumab in Patients with Advanced Solid Tumours | 1 |
| 18 | The changing landscape of systemic therapy in advanced pancreatic cancer | 1 |
| 19 | 31 | |
| 20 | 53 |
About Adnan Nagrial
Adnan Nagrial is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 116 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (43 papers), Pancreatic and Hepatic Oncology Research (36 papers) and Cancer Genomics and Diagnostics (28 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (453 citations) and Pulmonary and Respiratory Medicine (698 citations). Adnan Nagrial has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Richard Kefford, Richard A. Scolyer, Georgina V. Long, Alexander M. Menzies, Michael Hughes, Lauren E. Haydu, Graham J. Mann, Anne Hamilton, John F. Thompson and Venessa Chin. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.